Label: CLEAR FUTURE INTENSIVE SPOT TREATMENT- salicylic acid lotion

  • NDC Code(s): 42508-210-09
  • Packager: Arbonne International, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated July 21, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Salicylic Acid 2%

  • Purpose

    Acne Treatment

  • Uses

    • for the treatment of acne.
    • penetrates pores to reduce the number of acne pimples.
    • dries and helps clear up acne pimples and allows skin to heal.
  • Warnings

    For external use only

    When using this product

    • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
    • avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a doctor if irritation or redness develops and lasts.

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • cleanse the skin thoroughly before applying this product.
    • cover the entire affected area with a thin layer one to three times daily.
    • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
    • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
  • Other information

    STORAGE: 55°F–85°F

  • Inactive ingredients

    water, isopentyldiol, glyceryl stearate SE, glycerin, butyrospermum parkii (shea) butter, glyceryl behenate, myristyl myristate, propanediol, hamamelis virginiana (witch hazel) water, isostearic acid, alpha-glucan oligosaccharide, bakuchiol, polyglyceryl-4 caprate, argania spinosa kernel oil, camellia sinensis seed oil, sesamum indicum (sesame) seed oil, serenoa serrulata fruit extract, salix alba (willow) bark extract, calendula officinalis flower extract, salvia officinalis (sage) leaf extract, rhamnose, saccharide isomerate, beta-sitosterol, glucose, glucuronic acid, tocopherol, niacinamide, xanthan gum, tridecyl salicylate, isodecyl salicylate, myristyl laurate, acrylates/C10-30 alkyl acrylate crosspolymer, aminomethyl propanol, cetyl alcohol, caprylyl glycol, benzethonium chloride, benzoic acid, chlorphenesin, phenoxyethanol.

  • Questions or comments?

    1.800.272.6663

    Monday–Friday
    6 a.m.–6 p.m. Pacific time

  • SPL UNCLASSIFIED SECTION

    Distributed by
    Arbonne International, LLC
    9400 Jeronimo Road
    Irvine, CA 92618 USA

  • PRINCIPAL DISPLAY PANEL - 15 mL Tube Carton

    ARBONNE®

    CLEAR
    FUTURE®

    INTENSIVE ACNE
    SPOT TREATMENT

    SALICYLIC ACID 2%

    0.5 fl. oz. / 15 mL

    Principal Display Panel - 15 mL Tube Carton
  • INGREDIENTS AND APPEARANCE
    CLEAR FUTURE INTENSIVE SPOT TREATMENT 
    salicylic acid lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42508-210
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 mg  in 15 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    ISOPENTYLDIOL (UNII: 19NOL5474Q)  
    GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SHEA BUTTER (UNII: K49155WL9Y)  
    GLYCERYL DIBEHENATE (UNII: R8WTH25YS2)  
    MYRISTYL MYRISTATE (UNII: 4042ZC00DY)  
    PROPANEDIOL (UNII: 5965N8W85T)  
    HAMAMELIS VIRGINIANA TOP WATER (UNII: NT00Y05A2V)  
    ISOSTEARIC ACID (UNII: X33R8U0062)  
    .ALPHA.-GLUCAN OLIGOSACCHARIDE (UNII: S95658MI3W)  
    BAKUCHIOL (UNII: OT12HJU3AR)  
    POLYGLYCERYL-4 CAPRATE (UNII: 3N873UN885)  
    ARGAN OIL (UNII: 4V59G5UW9X)  
    CAMELLIA SINENSIS SEED OIL (UNII: O5R6DK2M9K)  
    SESAME OIL (UNII: QX10HYY4QV)  
    SAW PALMETTO (UNII: J7WWH9M8QS)  
    SALIX ALBA BARK (UNII: 205MXS71H7)  
    CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)  
    SAGE (UNII: 065C5D077J)  
    RHAMNOSE (UNII: QN34XC755A)  
    SACCHARIDE ISOMERATE (UNII: W8K377W98I)  
    .BETA.-SITOSTEROL (UNII: S347WMO6M4)  
    DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
    GLUCURONIC ACID (UNII: 8A5D83Q4RW)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    TRIDECYL SALICYLATE (UNII: AZQ08K38Z1)  
    ISODECYL SALICYLATE (UNII: S7097PFP4C)  
    MYRISTYL LAURATE (UNII: 58U0NZN2BT)  
    CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
    AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    BENZETHONIUM CHLORIDE (UNII: PH41D05744)  
    BENZOIC ACID (UNII: 8SKN0B0MIM)  
    CHLORPHENESIN (UNII: I670DAL4SZ)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:42508-210-091 in 1 CARTON04/01/2015
    115 mL in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH FINALpart333D04/01/2015
    Labeler - Arbonne International, LLC (961643454)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!